Citius Pharmaceuticals Inc
NASDAQ:CTXR

Watchlist Manager
Citius Pharmaceuticals Inc Logo
Citius Pharmaceuticals Inc
NASDAQ:CTXR
Watchlist
Price: 0.8408 USD 5.1% Market Closed
Market Cap: 14.3m USD

Wall Street
Price Targets

CTXR Price Targets Summary
Citius Pharmaceuticals Inc

Wall Street analysts forecast CTXR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTXR is 5.1 USD with a low forecast of 4.04 USD and a high forecast of 6.3 USD.

Lowest
Price Target
4.04 USD
380% Upside
Average
Price Target
5.1 USD
507% Upside
Highest
Price Target
6.3 USD
649% Upside
Citius Pharmaceuticals Inc Competitors:
Price Targets
PPLPHARMA
Piramal Pharma Ltd
51% Upside
GUD
Knight Therapeutics Inc
34% Upside
GRANULES
Granules India Ltd
1% Upside
SUPRIYA
Supriya Lifescience Ltd
17% Upside
LUPIN
Lupin Ltd
9% Upside
DMP
Dermapharm Holding SE
11% Upside
326030
SK Biopharmaceuticals Co Ltd
17% Upside
1681
Consun Pharmaceutical Group Ltd
21% Upside

Revenue
Forecast

Revenue Estimate
Citius Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Citius Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Citius Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CTXR's stock price target?
Price Target
5.1 USD

According to Wall Street analysts, the average 1-year price target for CTXR is 5.1 USD with a low forecast of 4.04 USD and a high forecast of 6.3 USD.

Back to Top